Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1284 results found. Search for [ Food and Drug Administration ]

Results 1 to 21 of 1284
BusinessToday.In
March 5, 2021
Shares of Wipro, Heranba Industries, Indiabulls Housing, Unichem Labs, Jagran Prakashan and others will be in focus in Friday's trading session


PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


PTI
March 2, 2021
The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray


Reuters
March 1, 2021
Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older


PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator


PTI
February 28, 2021
The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations, and death


Associated Press
February 27, 2021
The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US


PTI
February 26, 2021
The Food and Drug Administration said Thursday that it's allowing the additional option after reviewing new data from New York-based Pfizer and its German partner, BioNTech


Rashi Bisaria
New Delhi, February 25, 2021
Johnson & Johnson's single-dose COVID-19 vaccine effective, safe: FDA Drug maker Johnson & Johnson's single-shot COVID-19 vaccine is safe and effective as per the data submitted from its ongoing multi-national Phase 3 randomised, double-blind and placebo-controlled trials. This is what a  briefing document published by the US Food and Drug Administration (FDA) has said. Johnson & Johnson had sought emergency use authorisation for its vaccine on February 4. FDA's advisory co...


BusinessToday.In
February 24, 2021
The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilised variant of the SARS-CoV-2 S protein.


BusinessToday.In
February 19, 2021
The pharma share touched an intraday high of Rs 329.25, rising 7.74% on BSE


Reuters
February 19, 2021
Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine is highly likely to still protect against the concerning variant first discovered in South Africa


BusinessToday.In
February 19, 2021
Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers


BusinessToday.In
February 12, 2021
Stock Market News Updates Today: Earlier today, Sensex hit a record high of 51,804 and Nifty hit a lifetime high of 15,243


BusinessToday.In
February 11, 2021
Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


PB Jayakumar
February 9, 2021
Rhizen has retained commercialisation rights for India while also being the manufacturing and supply partner for Umbralisib. Alembic owns 50 per cent stake in Rhizen


BusinessToday.In
February 7, 2021
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.


PTI
February 7, 2021
The affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc


BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


BusinessToday.In
February 3, 2021
India Stock Market News Updates Today: IndusInd Bank, followed by Dr Reddy's, PowerGrid, Tech Mahindra, M&M, Sun Pharma and Axis Bank were among the top gainers. On the other hand, Maruti, Kotak Bank, SBI and UltraTech Cement were among the losers


PAGES 1 OF 65  12345